January 2016 Asbmb Today 1 President’S Message

Total Page:16

File Type:pdf, Size:1020Kb

Load more

CONTENTS NEWS FEATURES PERSPECTIVES 2 14 22 PRESIDENT’S MESSAGE QUANTUM BIOLOGY COORDINATES CONTINUES TO INTRIGUE Exiting the hobbit hole 5 10 NEWS FROM THE HILL 24 What’s on tap for 2016 MINORITY AFFAIRS 24 Research spotlight 6 26 Committee update MEMBER UPDATE 28 8 EDUCATION NEWS Why should you be an ASBMB 8 NIH retiring 50 reserve chimpanzees Student Chapters adviser? 9 Proteins get their own periodic table 12 30 10 CAREER INSIGHTS JOURNAL NEWS Working at a PUI 10 Implicating proteins in synaptic plasticity 11 When the good and the bad make the ugly 24 12 JLR co-editor in chief steps down 13 e details of DNA end resection 7 14 Rajendrani Mukhopadhyay on the comeback of quantum mechanics in molecular biology. 22 JANUARY 2016 ASBMB TODAY 1 PRESIDENT’S MESSAGE THE MEMBER MAGAZINE OF THE AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY PCP addict By Steven McKnight OFFICERS COUNCIL MEMBERS Steven McKnight Squire J. Booker President Karen G. Fleming Gregory Gatto Jr. o — I’m not talking about Were it up to me — and as I have Natalie Ahn Rachel Green phencyclidine or angel dust but admitted over and over, it is not — I President-Elect Susan Marqusee instead PCP as an abbreviation would never fund a research project Jared Rutter N Karen Allen Secretary Brenda Schulman for three words: phenomenon, curios- that did not do one of two things. A Michael Summers ity and paradox. worthy project should either question Toni Antalis Treasurer ASBMB TODAY EDITORIAL My 1973 edition of Webster’s our existing assumptions or propose ADVISORY BOARD New Collegiate Dictionary denes a an uncharted pathway directed toward EX-OFFICIO MEMBERS Charles Brenner phenomenon as “a rare or signicant an unexplained biological phenom- Squire Booker Chair fact or event,” a curiosity as “one enon. Wei Yang Michael Bradley Co-chairs, 2016 Annual Floyd “Ski” Chilton that arouses interest especially for Knowing that my advice is anti- Meeting Program Cristy Gelling uncommon or exotic characteristics,” thetical to the status quo, I start with Committee Peter J. Kennelly and a paradox as “a tenet contrary to the truth-in-advertising warning that Rajini Rao Peter J. Kennelly received opinion.” I’m always on the the thoughts presented herein are Chair, Education and Yolanda Sanchez Professional Development Shiladitya Sengupta lookout for any PCP worthy of study. anti-professional. Follow this advice, Committee Carol Shoulders Once I nd a good one, I see the and you are almost certain to get your Daniel Raben opportunity to make a discovery. grant application triaged. Chair, Meetings Committee ASBMB TODAY Angela Hopp Before discussing ways of nding PCPs abound in biology. ey hit Takita Felder Sumter Executive Editor, Chair, Minority Aairs PCPs, let’s rst question the value of us in the face without even looking for [email protected] Committee this strategy. them. Some may defy conventional Lauren Dockett omas Baldwin Managing Editor, With respect to practicality wisdom and be paradoxical, others Chair, Outreach Committee [email protected] (careerism), this approach is a bad may constitute little more than weird Wes Sundquist Rajendrani Mukhopadhyay idea. Committing to a project that is curiosities, and still others may rest Chair, Public Aairs Chief Science Correspondent, Advisory Committee [email protected] unusual, exotic or contrary to opinion on a newly observed phenomenon of Blake Hill Valery Masterson is not easy. Granting agencies tend to interest. Chair, Publications Designer, choke on ideas that are new, dier- I bump into PCPs on a regular Committee [email protected] Lauri Pantos ent or a challenge to conventional basis. Here are several examples that F. Peter Guengerich Manager of Publications wisdom. ey want us to add incre- I thought of without getting up from Interim editor-in-chief, JBC Technology, [email protected] mentally to the existing knowledge my chair. Herbert Tabor Ciarán Finn Co-editor, JBC Web Publication Assistant, base; they want to know that what Starting with the phenomenon [email protected] A. L. Burlingame we propose in our grant applications category of the PCP triad, I recount a Editor, MCP Allison Frick Media Specialist, will work. Nothing I’ve ever known conversation I had recently with my Edward A. Dennis [email protected] for sure will work and proceeded to colleague, Betsy Goldsmith. Betsy William L. Smith Barbara Gordon do has added anything of signicance. is interested in how cells respond to Co-editors, JLR Executive Director, [email protected] If a project is perceived as likely to changes in osmotic pressure. Much to succeed, building on what already is her surprise, Betsy found an enzyme known and accepted, it is far more that is pressure sensitive and involved For information on advertising, contact Pharmaceutical Media Inc. at 212-904-0374 or [email protected]. digestible to most review committees in a signaling cascade that responds than a project seeking to challenge to extracellular osmolarity. How crazy dogma or break new ground. and cool is this? An enzyme that is www.asbmb.org/asbmbtoday PRINT ISSN 2372-0409 Correction Articles published in ASBMB Today reect solely the authors’ views and not the ocial positions of e article “More good news about aspirin” in the October 2015 issue of the American Society for Biochemistry and Molecular ASBMB Today incorrectly referred to salicylate as an acetylated form of Biology or the institutions with which the authors are aliated. Mentions of products or services are aspirin. It is an unacetylated form of aspirin. not endorsements. ©2015 ASBMB 2 ASBMB TODAY JANUARY 2016 pressure sensitive! Betsy sticks her the ultraconserved intronic elements technical hurdles might be way too enzyme in a test tube, pumps up the of the NPAS3 genes as to its protein- high, or our instincts may simply be pressure, and the enzyme activates coding exons. is is a curiosity. dead wrong. magically. Talk about a cool phenom- I’ll close with a paradox. Several PCP projects are risky. We all know enon! years ago, my trainees and I stumbled this. What if our system of grant fund- Moving to the curiosity category, I onto the fact that low-complexity ing, instead of betting on sure winners turn to a gene my lab has studied for a sequences associated with many DNA guaranteed of incremental advance, while — the gene encoding a tran- and RNA regulatory proteins can instead demanded that each funded scription factor that we call neuronal polymerize into amyloidlike bers. project aim at a unique phenomenon, PAS domain protein 3, or NPAS3. Intuition and certain experimental curiosity or paradox? A small fraction e NPAS3 gene has ridiculously large observations led us to hypothesize that of the annual budget of the National introns. Two of the introns span nearly there might be biologic utility to LC Institutes of Health is indeed devoted a million base pairs. Geez, it takes the sequence polymerization. Whether to high-risk, high-reward projects — RNA polymerase II enzyme ve to 10 we are right or wrong on this remains perhaps 1 percent in aggregate. Why hours simply to transcribe the gene open to question. e paradox that is do we not devote a higher fraction of from end to end. Other genes are big, clear, however, is that the amyloidlike biomedical research funding to crazy so the whalelike size of NPAS3 introns bers polymerized from LC sequences exploration? is not all that perplexing. Cool and are labile. is is crazy. As visualized e success rate of PCP-funded unexpected is the fact that the introns by electron microscopy, LC amyloids projects would be modest. Many of the NPAS3 gene contain hundreds look just like pathogenic amyloids that would fail. By contrast, the small of ultraconserved elements 100 to 300 are rock solid and at the heart of many number of wins might accelerate base pairs in length. ese elements forms of neurodegenerative disease. our understanding of how biological have been conserved for upward of How can two amyloid bers look the systems actually work. e careers half a billion years, going back to the same yet be entirely dierent with of scientists crazy enough to expend evolutionary time when our ancestors respect to lability? their shot on the goal of a four-year diverged from teleost sh. I happen to believe that these three period of grant funding on a wild and e intronic sequences of the PCPs are pregnant with discovery. crazy project might well decay and die NPAS3 gene are conserved to an at is the good news, and that is on the journey. Despite this risk, I’m extent equal to the handful of exons what causes me to adore my job. e thinking that the line for those bold that encode the polypeptide sequence bad news is that I can’t be sure that enough to give PCP a try might be of the NPAS3 protein. If we knew studies of Betsy’s pressure-sensitive long. nothing about exons, introns, proteins enzyme, the ultraconserved intronic — nothing about the central dogma elements of the NPAS3 gene or our Steven McKnight (steven. of molecular biology — yet were able labile amyloids will illuminate our [email protected]) is president of the American to sequence and comparatively align understanding of biology. Instincts tell Society for Biochemistry and the NPAS3 genes from dozens of me they will, but these are the sorts of Molecular Biology and chairman vertebrates, evolution would be telling projects that most grant review groups of the biochemistry department at the University us to pay just as much attention to would automatically reject — the of Texas-Southwestern Medical Center at Dallas. JANUARY 2016 ASBMB TODAY 3 Submit Your Next Paper to an ASBMB Journal! When you submit a paper to an ASBMB ASBMB journal special features: journal, you can expect: • Customized eTOC alerts • Thorough, constructive reviews by scientists • Explore the Editorial Board • Affordable publication charges (*FREE color) • Meet new Associate Editors • Peer reviewed papers published the day of • Read Collections including: Reflections, acceptance Minireviews and Thematic Series *ASBMB has eliminated color figure fees for Regular ASBMB www.asbmb.org/publications members publishing as corresponding authors.
Recommended publications
  • The EMBL-European Bioinformatics Institute the Hub for Bioinformatics in Europe

    The EMBL-European Bioinformatics Institute the Hub for Bioinformatics in Europe

    The EMBL-European Bioinformatics Institute The hub for bioinformatics in Europe Blaise T.F. Alako, PhD [email protected] www.ebi.ac.uk What is EMBL-EBI? • Part of the European Molecular Biology Laboratory • International, non-profit research institute • Europe’s hub for biological data, services and research The European Molecular Biology Laboratory Heidelberg Hamburg Hinxton, Cambridge Basic research Structural biology Bioinformatics Administration Grenoble Monterotondo, Rome EMBO EMBL staff: 1500 people Structural biology Mouse biology >60 nationalities EMBL member states Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom Associate member state: Australia Who we are ~500 members of staff ~400 work in services & support >53 nationalities ~120 focus on basic research EMBL-EBI’s mission • Provide freely available data and bioinformatics services to all facets of the scientific community in ways that promote scientific progress • Contribute to the advancement of biology through basic investigator-driven research in bioinformatics • Provide advanced bioinformatics training to scientists at all levels, from PhD students to independent investigators • Help disseminate cutting-edge technologies to industry • Coordinate biological data provision throughout Europe Services Data and tools for molecular life science www.ebi.ac.uk/services Browse our services 9 What services do we provide? Labs around the
  • Functional Effects Detailed Research Plan

    Functional Effects Detailed Research Plan

    GeCIP Detailed Research Plan Form Background The Genomics England Clinical Interpretation Partnership (GeCIP) brings together researchers, clinicians and trainees from both academia and the NHS to analyse, refine and make new discoveries from the data from the 100,000 Genomes Project. The aims of the partnerships are: 1. To optimise: • clinical data and sample collection • clinical reporting • data validation and interpretation. 2. To improve understanding of the implications of genomic findings and improve the accuracy and reliability of information fed back to patients. To add to knowledge of the genetic basis of disease. 3. To provide a sustainable thriving training environment. The initial wave of GeCIP domains was announced in June 2015 following a first round of applications in January 2015. On the 18th June 2015 we invited the inaugurated GeCIP domains to develop more detailed research plans working closely with Genomics England. These will be used to ensure that the plans are complimentary and add real value across the GeCIP portfolio and address the aims and objectives of the 100,000 Genomes Project. They will be shared with the MRC, Wellcome Trust, NIHR and Cancer Research UK as existing members of the GeCIP Board to give advance warning and manage funding requests to maximise the funds available to each domain. However, formal applications will then be required to be submitted to individual funders. They will allow Genomics England to plan shared core analyses and the required research and computing infrastructure to support the proposed research. They will also form the basis of assessment by the Project’s Access Review Committee, to permit access to data.
  • Exploring the Structure and Function Paradigm Oliver C Redfern, Benoit Dessailly and Christine a Orengo

    Exploring the Structure and Function Paradigm Oliver C Redfern, Benoit Dessailly and Christine a Orengo

    Available online at www.sciencedirect.com Exploring the structure and function paradigm Oliver C Redfern, Benoit Dessailly and Christine A Orengo Advances in protein structure determination, led by the Figure 1 shows that as the international genomics initiat- structural genomics initiatives have increased the proportion of ives gather pace, both the number of sequences and novel folds deposited in the Protein Data Bank. However, these protein families are still growing at an exponential rate, structures are often not accompanied by functional annotations although the rate of expansion of protein families is with experimental confirmation. In this review, we reassess the substantially less. This trend is also observed among meaning of structural novelty and examine its relevance domain families, which are 10-fold fewer (<10 000) than to the complexity of the structure-function paradigm. the number of protein families. By targeting these, the Recent advances in the prediction of protein function from structural genomics initiatives can aim to characterise the structure are discussed, as well as new sequence-based major building blocks of whole proteins and since these methods for partitioning large, diverse superfamilies into domains recur in different combination in the genomes, it biologically meaningful clusters. Obtaining structural data for will be an important step towards understanding the these functionally coherent groups of proteins will allow us to complete structural repertoire in nature. Furthermore, better understand the relationship between structure and the complement of molecular functions found within function. an organism is likely to be even fewer. For example, 97% of proteins in yeast can be assigned one or more of Address 4000 unique GO terms.
  • EMBO Facts & Figures

    EMBO Facts & Figures

    excellence in life sciences Reykjavik Helsinki Oslo Stockholm Tallinn EMBO facts & figures & EMBO facts Copenhagen Dublin Amsterdam Berlin Warsaw London Brussels Prague Luxembourg Paris Vienna Bratislava Budapest Bern Ljubljana Zagreb Rome Madrid Ankara Lisbon Athens Jerusalem EMBO facts & figures HIGHLIGHTS CONTACT EMBO & EMBC EMBO Long-Term Fellowships Five Advanced Fellows are selected (page ). Long-Term and Short-Term Fellowships are awarded. The Fellows’ EMBO Young Investigators Meeting is held in Heidelberg in June . EMBO Installation Grants New EMBO Members & EMBO elects new members (page ), selects Young EMBO Women in Science Young Investigators Investigators (page ) and eight Installation Grantees Gerlind Wallon EMBO Scientific Publications (page ). Programme Manager Bernd Pulverer S Maria Leptin Deputy Director Head A EMBO Science Policy Issues report on quotas in academia to assure gender balance. R EMBO Director + + A Conducts workshops on emerging biotechnologies and on H T cognitive genomics. Gives invited talks at US National Academy E IC of Sciences, International Summit on Human Genome Editing, I H 5 D MAN 201 O N Washington, DC.; World Congress on Research Integrity, Rio de A M Janeiro; International Scienti c Advisory Board for the Centre for Eilish Craddock IT 2 015 Mammalian Synthetic Biology, Edinburgh. Personal Assistant to EMBO Fellowships EMBO Scientific Publications EMBO Gold Medal Sarah Teichmann and Ido Amit receive the EMBO Gold the EMBO Director David del Álamo Thomas Lemberger Medal (page ). + Programme Manager Deputy Head EMBO Global Activities India and Singapore sign agreements to become EMBC Associate + + Member States. EMBO Courses & Workshops More than , participants from countries attend 6th scienti c events (page ); participants attend EMBO Laboratory Management Courses (page ); rst online course EMBO Courses & Workshops recorded in collaboration with iBiology.
  • Statistical and Computational Methods for Analyzing High-Throughout Genomic Data

    Statistical and Computational Methods for Analyzing High-Throughout Genomic Data

    Statistical and Computational Methods for Analyzing High-Throughout Genomic Data by Jingyi Li A dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Biostatistics and the Designated Emphasis in Computational and Genomic Biology in the Graduate Division of the University of California, Berkeley Committee in charge: Professor Peter J. Bickel, Chair Professor Haiyan Huang Professor Sandrine Dudoit Professor Steven E. Brenner Spring 2013 Statistical and Computational Methods for Analyzing High-Throughput Genomic Data Copyright 2013 by Jingyi Li 1 Abstract Statistical and Computational Methods for Analyzing High-Throughput Genomic Data by Jingyi Li Doctor of Philosophy in Biostatistics and the Designated Emphasis in Computational and Genomic Biology University of California, Berkeley Professor Peter J. Bickel, Chair In the burgeoning field of genomics, high-throughput technologies (e.g. microarrays, next-generation sequencing and label-free mass spectrometry) have enabled biologists to perform global analysis on thousands of genes, mRNAs and proteins simultaneously. Ex- tracting useful information from enormous amounts of high-throughput genomic data is an increasingly pressing challenge to statistical and computational science. In this thesis, I will address three problems in which statistical and computational methods were used to analyze high-throughput genomic data to answer important biological questions. The first part of this thesis focuses on addressing an important question in genomics: how to identify and quantify mRNA products of gene transcription (i.e., isoforms) from next- generation mRNA sequencing (RNA-Seq) data? We developed a statistical method called Sparse Linear modeling of RNA-Seq data for Isoform Discovery and abundance Estimation (SLIDE) that employs probabilistic modeling and L1 sparse estimation to answer this ques- tion.
  • Janet Thornton Ing for Future Research Needs

    Janet Thornton Ing for Future Research Needs

    THIS MONTH are dedicated to developing and maintaining services THE AUTHOR FILE for the scientific community, including databases such as the genome portal Ensembl, the proteomic data- base UniProt and more, all of which requires strategiz- Janet Thornton ing for future research needs. “These resources don’t Finding ways to navigate the reactions happen overnight; they’re big teams and they have to of life and herd tigers are all part of her think carefully,” she says. workday. Fostering collaborative science internally and across organizational and national boundaries such as for The wealth of available sequenced genomes invites sci- the project ELIXIR—the European life sciences infra- entists to explore the molecular basis of life, to browse structure for biological information, a pan-European and parse the beautiful infrastructure she has spearheaded to help scientists complexity of this now share data—is hard work, especially in times of fiscal “open book,” says Janet belt-tightening. At times, Thornton says, the task can Thornton. feel more like “herding tigers” than cats. A physicist turned Overall she sees the role of computational biology computational shifting, she says. In physics, work by experimentalists biologist, Thornton led to theoretical lines of inquiry. Biology is in its data- directs the European gathering stage, and rapidly moving toward the ability Bioinformatics to model processes such as the effect of a drug on the Institute (EBI), where human body. “We’re only a fraction of the way towards she has cultivated being able to do that,” she says, but she believes the EBI interdisciplinary EBI’s resources help to create the “bedrock” for this teamwork since 2001.
  • Protein Family and Fold Occurrence in Genomes: Power-Law Behaviour and Evolutionary Model Jiang Qian, Nicholas M

    Protein Family and Fold Occurrence in Genomes: Power-Law Behaviour and Evolutionary Model Jiang Qian, Nicholas M

    doi:10.1006/jmbi.2001.5079 available online at http://www.idealibrary.com on J. Mol. Biol. (2001) 313, 673±681 COMMUNICATION Protein Family and Fold Occurrence in Genomes: Power-law Behaviour and Evolutionary Model Jiang Qian, Nicholas M. Luscombe and Mark Gerstein* Department of Molecular Global surveys of genomes measure the usage of essential molecular Biophysics and Biochemistry parts, de®ned here as protein families, superfamilies or folds, in different Yale University, 266 Whitney organisms. Based on surveys of the ®rst 20 completely sequenced gen- Avenue, PO Box 208114, New omes, we observe that the occurrence of these parts follows a power-law Haven, CT 06520-8114, USA distribution. That is, the number of distinct parts (F) with a given geno- mic occurrence (V) decays as F aVb, with a few parts occurring many times and most occurring infrequently. For a given organism, the distri- butions of families, superfamilies and folds are nearly identical, and this is re¯ected in the size of the decay exponent b. Moreover, the exponent varies between different organisms, with those of smaller genomes dis- playing a steeper decay (i.e. larger b). Clearly, the power law indicates a preference to duplicate genes that encode for molecular parts which are already common. Here, we present a minimal, but biologically meaning- ful model that accurately describes the observed power law. Although the model performs equally well for all three protein classes, we focus on the occurrence of folds in preference to families and superfamilies. This is because folds are comparatively insensitive to the effects of point mutations that can cause a family member to diverge beyond detectable similarity.
  • Cold Spring Harbor Laboratory 2016 Meetings & Courses

    Cold Spring Harbor Laboratory 2016 Meetings & Courses

    Cold Spring Harbor Laboratory 2016 Meetings & Courses Meetings Gene Expression & Signaling in the Glia in Health & Disease Axon Guidance, Synapse Formation & Regeneration Immune System July 21 - 25 abstracts due May 6 September 20 - 24 abstracts due July 1 Marc Freeman, Kelly Monk Greg Bashaw, Linda Richards, Peter Scheiffele Systems Biology: Global Regulation of April 26 - 30 abstracts due February 5 Gene Expression Diane Mathis, Stephen Nutt, Alexander Rudensky, Art Weiss Genome Engineering: The CRISPR/Cas Revolution August 17 - 20 abstracts due May 27 Mechanisms of Aging March 15 - 19 abstracts due January 8 September 26 - 30 abstracts due July 25 Nuclear Organization & Function Jennifer Doudna, Maria Jasin, Jonathan Weissman Barak Cohen, Christina Leslie, John Stamatoyannopoulos, Sarah Teichmann Vera Gorbunova, Malene Hansen, Scott Pletcher May 3 - 7 abstracts due February 12 Evolutionary Biology of Caenorhabditis & Edith Heard, Martin Hetzer, David Spector Regulatory & Non-Coding RNAs August 23 - 27 abstracts due June 3 Germ Cells October 4 - 8 abstracts due July 15 Other Nematodes The Biology of Genomes Victor Ambros, Elisa Izaurralde, Nicholas Proudfoot Robert Braun, Geraldine Seydoux March 30 - April 2 abstracts due January 15 May 10 - 14 abstracts due February 19 Scott Baird, Marie Delattre, Erik Ragsdale, Adrian Streit Ewan Birney, Michel Georges, Jonathan Pritchard, Molly Przeworski The PI3K-mTOR-PTEN Network in Biological Data Science Neuronal Circuits The Cell Cycle Health & Disease October 25 - 29 abstracts due August 12
  • ISMB 2016 Offers Outstanding Science, Networking, and Celebration [Version 1; Peer Review: Not Peer Reviewed] Christiana N

    ISMB 2016 Offers Outstanding Science, Networking, and Celebration [Version 1; Peer Review: Not Peer Reviewed] Christiana N

    F1000Research 2016, 5(ISCB Comm J):1371 Last updated: 09 APR 2020 EDITORIAL ISMB 2016 offers outstanding science, networking, and celebration [version 1; peer review: not peer reviewed] Christiana N. Fogg International Society for Computational Biology, La Jolla, CA, USA First published: 14 Jun 2016, 5(ISCB Comm J):1371 ( Not Peer Reviewed v1 https://doi.org/10.12688/f1000research.8640.1) Latest published: 14 Jun 2016, 5(ISCB Comm J):1371 ( This article is an Editorial and has not been subject https://doi.org/10.12688/f1000research.8640.1) to external peer review. Abstract Any comments on the article can be found at the The annual international conference on Intelligent Systems for Molecular Biology (ISMB) is the major meeting of the International Society for end of the article. Computational Biology (ISCB). Over the past 23 years the ISMB conference has grown to become the world's largest bioinformatics/computational biology conference. ISMB 2016 will be the year's most important computational biology event globally. The conferences provide a multidisciplinary forum for disseminating the latest developments in bioinformatics/computational biology. ISMB brings together scientists from computer science, molecular biology, mathematics, statistics and related fields. Its principal focus is on the development and application of advanced computational methods for biological problems. ISMB 2016 offers the strongest scientific program and the broadest scope of any international bioinformatics/computational biology conference. Building on past successes, the conference is designed to cater to variety of disciplines within the bioinformatics/computational biology community. ISMB 2016 takes place July 8 - 12 at the Swan and Dolphin Hotel in Orlando, Florida, United States.
  • Genomics 2016

    Genomics 2016

    Quantitative Genomics 2016 Student Conference QUANTITATIVE 6 June GENOMICS 2016 University College London (UCL) ! @quantgen16 #quantgen16 Content Page Conference programme 2 Keynote Talks 4 Sponsored Talk 5 Meet the organisers 6 Abstracts: sessions 7 Abstracts: poster presentations 21 Sponsored by Page 1& Quantitative Genomics 2016 Conference programme, first half Registration and coffee 9:00 – 9.30 Session 1: Complex Phenotype Genetics 9.30 – 10.30 9.30 - 9.45 · Hannes Svardal, Wellcome Trust Sanger Institute Africa-wide whole genome sequencing of vervet monkeys reveals strong polygenic selection on known HIV-interacting genes and on genes up-regulated after infection with the simian immunodeficiency virus (SIV) 9.45 - 9.50 · Jonathan Coleman, Institute of Psychiatry, Psychology and Neuroscience, King’s College London The contribution of polygenic risk to the relationship between depression and body mass index in the UK Biobank 9.50 - 10.05 · Stefan Dentro, Wellcome Trust Sanger Institute Large-scale pan-cancer subclonal reconstruction analysis of whole genome sequences reveals wide-spread intra- tumour heterogeneity 10.05 - 10.10 · Eva Krapohl, King’s College London The nature of nurture: Education-associated single nucleotide polymorphisms explain variation in children's home environments and in their associations with child outcomes 10.10 - 10.25 · Hannah Meyer, European Bioinformatics Institute Understanding cardiac structure and function in humans using 4D imaging genetics. 10.25 - 10.30 · Richa Gupta, University of Helsinki Neuregulin
  • Physical and Chemical Foundations of Bioinformatics Methods June 18 - 22, 2007 Scientific Coordination: Markus Porto H

    Physical and Chemical Foundations of Bioinformatics Methods June 18 - 22, 2007 Scientific Coordination: Markus Porto H

    Max-Planck-Institut fur¨ Physik komplexer Systeme, Dresden, Germany International Workshop on Physical and Chemical Foundations of Bioinformatics Methods June 18 - 22, 2007 Scientific Coordination: Markus Porto H. Eduardo Roman Michele Vendruscolo Technische Universit¨at Darmstadt Universit`adi Milano-Bicocca University of Cambridge Darmstadt, Germany Milano, Italy Cambridge, UK Organisation: Claudia P¨onisch MPI f¨ur Physik komplexer Systeme Dresden, Germany Bioinformatics is a recent discipline developed to organize and analyse the wealth of biological data generated by large scale programmes such as genome projects and structural genomics initiatives. Today, this disci- pline constitutes a very active and mature area of research that provides efficient algorithms for a variety of applications, including sequence alignment, gene detection, and structure comparison. So far, however, the physical and chemical foundations of the methodologies developed in Bioinformatics have not been explored with the necessary depth. Progress in understanding the structural properties of biological entities, including their physical and chemical interactions, can greatly help to improve existing bioinformatics methods, and ultimately suggesting new approaches. We aim at bringing together researchers from different scientific communities working within the following three main areas: (i) methodological developments in Bioinformatics, (ii) experimental and (iii) computational studies of the properties of biological macromolecules. Possible synergies between
  • Research at EMBL-EBI

    Research at EMBL-EBI

    Key facts about research at EMBL-EBI Research at EMBL-EBI • A unique environment for bioinformatics research Data-driven discovery • 9 dedicated research groups • 6 services teams also carry out R&D • Research and services are mutually supportive Nick Goldman www.ebi.ac.uk/research Research Group Leaders Research themes Genes Key Genes Ewan Paul Nick Birney Flicek Goldman Biology •Nick Goldman •Ewan Birney Physics •Paul Flicek Chemical biology Maths Expression •Christoph Steinbeck Chemistry •John Overington Alvis Anton John Oliver Expression Brazma Enright Marioni Expression Stegle •Anton Enright •John Marioni Proteins & structures •Oliver Stegle •Alvis Brazma Systems biology Alex Pedro Gerard Janet Systems biology Bateman Beltrao Kleywegt Thornton •Paul Bertone Proteins & structures •Julio Saez-Rodriguez •Sarah Teichmann Systems biology Chemical biology •Janet Thornton •Pedro Beltrao Paul Julio Saez- Sarah John Christoph Bertone Rodriguez Teichmann Overington Steinbeck •Alex Bateman •Gerard Kleywegt Genes & expression Proteins, structures & chemical biology • Birney: Sequence algorithms and intra-species variation • Bateman: Analysis of protein and RNA sequence • BrazmaBrazma:: Functional genomics research • BeltraoBeltrao:: Evolution of cellular networks • EnrightEnright:: Functional genomics and analysis of small RNA function • OveringtonOverington:: Drug discovery informatics • FlicekFlicek:: Evolution of transcriptional regulation • Steinbeck: Small molecule metabolism in biological systems • Goldman: Evolutionary tools for genomic